Vaccines Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Trusted Voices
You’ve Still Got It: Aging with Agency to Stay on Top of Your Health Year-Round
by Aamir Malik Aamir Malik is Executive Vice President, Chief U.S. Commercial Officer, Pfizer Inc. and a member of Pfizer's Executive Leadership Team. Today, he writes about the importance of taking control of your health as you age, and shares advice from Leticia Acevedo, a North Carolina-based nursing professional and professor.Nowadays, people are striving to live their best lives — traveling, dancing, learning new skills, and embracing life with energy and purpose — all the while showing us...
Programs & Initiatives
Not for Granted: Pediatric Immunization Through Experts’ Lens
New survey fielded by Excellence in Pediatrics Institute, with support from Pfizer, aims to uncover challenges and find solutions to gaps in pediatric vaccination rates in Europe
Science & Innovation
Viral vs Bacterial Infections: Different Pathogens, Different Approaches
When you experience symptoms of an infection such as fever, fatigue, decreased appetite, or pain, knowing whether a virus or bacteria is making you sick may be the key to getting the right treatment and feeling better.1,2Viruses and bacteria are among the most well-known causes of infection.3 Infections occur when viruses or bacteria invade the human host and proliferate.3 But there are some important distinctions between them, and it’s important to determine whether it’s a bacteria or virus...
Science & Innovation
What You Need to Know About a Promising Vaccine Candidate that May Stem the Growing Risk of Lyme Disease
Lyme disease is the most common vector-borne illness in the United States.1 The U.S. Centers for Disease Control and Prevention (CDC) says that state health departments reported over 63,000 cases in 2022.2 However, the CDC uses other methods to estimate that approximately 476,000 people in the U.S. may be diagnosed and treated for Lyme disease annually.2In other words, the estimated number of Lyme disease cases in the U.S. seems to be much higher than what is being reported to public health...
Purpose & Ideals
An Accord for a Healthier World: Working Together to Help Address Unmet Healthcare Needs in Lower-Income Countries
Currently, regulatory agencies may take up to seven years to approve essential medicines and vaccines in low- and middle-income counties (LMICs) from the time those same treatments were first approved in high-income countries, if they are approved at all.1 The burden remains disproportionately higher in low-income countries.2 Lack of access to quality healthcare is related to healthcare inequities in LMICs and hinders equitable access to safe and effective treatments.2Those living in LMICs...
Programs & Initiatives
Operation Eradication: The Global Health Community Comes Together to Defeat Meningitis by 2030
Bacterial meningitis strikes fast. Within hours, a fever, headache, nausea, and stiff neck can lead to brain damage, hearing loss, and other permanent disabilities, and potentially even death.1,2 Meningitis stems from infection in the fluid around the brain and spinal cord, causing inflammation to the membranes surrounding them, called meninges.1,3 Bacterial meningitis is the most common form of the illness. As its name suggests, bacteria like Haemophilus influenzae (type B), Streptococcus...
Programs & Initiatives
Three Pfizer Partnerships to Get the COVID-19 Vaccine into African Countries and Vaccinations into Arms
In 2020, as Pfizer and BioNTech were still developing the COVID-19 vaccine, Julie Jenson was thinking about how to distribute that vaccine to every country around the world, regardless of that country’s means. Jenson, who is Director of International Product Access for Pfizer’s Global Health and Social Impact Team, knew even in those early days that the ultracold storage demands and shipping requirements of the vaccine could pose challenges in reaching people living in remote areas of low- and...
Living & Wellbeing
Understanding Six Types of Vaccine Technologies
Ever since the first vaccine was developed in 1796 to treat smallpox,1 several different methods have been created to develop successful vaccines. Today, those methods, known as vaccine technologies, are more advanced and use the latest technology to help protect the world from preventable diseases.2Depending on the pathogen (a bacteria or virus) that is being targeted, different vaccine technologies are used to generate an effective vaccine. Just like there are multiple ways to develop a...
Science & Innovation
What Makes an RNA Vaccine Different From a Conventional Vaccine?
Vaccines are one of the greatest health interventions ever developed. They’ve been cited as being as important to keeping communities healthy as having access to clean water and safe sanitation.1Through scientific investment and ingenuity, today we have multiple vaccine technology platforms that have helped us control and, in some cases, eradicate many healthcare challenges such as polio, river blindness, smallpox, and COVID-19, just to name a few.In 2020, messenger RNA, or mRNA for short, was...
Science & Innovation
Maternal Immunization: Protecting Children from RSV and GBS
In the first few months of their lives, infants experience new sights, sounds, scents, and textures. During this time, they also make contact with new organisms. It takes up to three months for portions of infants’ still-developing immune systems to mature.1 During these early weeks and months, infants are too young to receive their first vaccines, leaving them vulnerable to developing serious infections.2Most pregnant people transmit antibodies to their developing fetuses naturally starting in...
Living & Wellbeing
6 Mosquito Diseases That Can Be Deadly
Mosquitoes won’t just ruin a cookout or leave angry red welts on your skin after a blood meal; the little buzzers might also transmit serious diseases. Mosquitoes are "silent" feeders; their siphon-like mouthparts can quickly pierce human skin and feed on blood without causing any notice, says Patrick Kelly PhD, director of Global Epidemiology for Tick Borne Diseases for Pfizer. He calls it “highly efficient feeding that has been fine-tuned over millions of years.” Mosquitos have taken...
Living & Wellbeing
The Truth About COVID-19 and Black Fungus
The novel coronavirus has recently been linked to two serious fungal infections: COVID-19 associated pulmonary aspergillosis (CAPA) and COVID-19 associated mucormycosis (CAM).1 The resurgence of these rare fungal infections has medical personnel concerned. A 2021 study found that more than 47,000 cases of CAM were reported in just three months in India. And with the Delta variant spreading worldwide, reports suggest that the number of cases is likely much higher.2 Aspergillosis and...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.